Ellen Schneider, MD
Family Practice · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Schneider’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G79646 · Current
Licensed to practise in California · since 1994 · expires 2028-07-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$60,036
Medicare paid this office $60,036 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 70 | $15,620 | $159 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 96 | $15,110 | $157 |
| Return visit (30+ min) | 71 | $8,366 | $107 |
| Short return visit (20+ min) | 59 | $5,568 | $74 |
| Sarscov2 vac 50 mcg/0.5ml im | 23 | $4,031 | $149 |
See all 9 services
| Long return visit (40+ min) | 70 | $15,620 | $159 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 96 | $15,110 | $157 |
| Return visit (30+ min) | 71 | $8,366 | $107 |
| Short return visit (20+ min) | 59 | $5,568 | $74 |
| Sarscov2 vac 50 mcg/0.5ml im | 23 | $4,031 | $149 |
| Influenza vaccine, inactivated | 19 | $1,555 | $82 |
| Admn sarscov2 vacc 1 dose | 23 | $1,407 | $52 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $953 | $53 |
| Administration of influenza virus vaccine | 22 | $860 | $39 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 76 · Women 65% · Health risk score 0.85. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 59% · Cancer 20% · Coronary heart disease 19% · Diabetes 13% · Chronic kidney disease 13% · Atrial fibrillation 13% · Depression 11% · Heart failure 9% · COPD 9% · Dementia 8%.
The office billed $149,171, Medicare allowed $73,737 and paid $60,036; for 515 services of 26 kinds; $6,733 of it was for drugs given in the office and $53,304 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 152 | 515 | 76 | 0.85 | $149,171 | $60,036 |
| 2023 | 159 | 449 | 76 | 0.75 | $135,886 | $53,972 |
| 2022 | 144 | 377 | 76 | 0.83 | $109,509 | $44,648 |
| 2021 | 130 | 381 | 76 | 0.83 | $107,789 | $43,662 |
| 2020 | 121 | 379 | 75 | 0.94 | $99,907 | $36,682 |
| 2019 | 135 | 715 | 74 | 0.88 | $113,953 | $38,809 |
| 2018 | 130 | 726 | 73 | 0.80 | $107,980 | $39,482 |
| 2017 | 124 | 971 | 73 | 0.81 | $96,157 | $34,004 |
| 2016 | 129 | 534 | 72 | 0.76 | $90,843 | $33,364 |
| 2015 | 112 | 680 | 73 | 0.73 | $73,196 | $31,987 |
| 2014 | 100 | 395 | 73 | 0.69 | $55,573 | $19,207 |
| 2013 | 77 | 231 | 72 | 0.83 | $52,023 | $17,413 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 88 | $14,040 | $160 |
| Long return visit (40+ min) | 65 | $13,426 | $146 |
| Return visit (30+ min) | 84 | $11,120 | $108 |
| Short return visit (20+ min) | 53 | $4,405 | $77 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | $828 | $75 |
| Administration of influenza virus vaccine | 18 | $681 | $38 |
2022: 6 services
| Long return visit (40+ min) | 70 | $14,391 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 76 | $12,021 | $158 |
| Return visit (30+ min) | 61 | $8,080 | $105 |
| Short return visit (20+ min) | 42 | $3,144 | $75 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 12 | $843 | $70 |
| Administration of influenza virus vaccine | 15 | $567 | $38 |
2021: 6 services
| Long return visit (40+ min) | 62 | $15,012 | $156 |
| Return visit (30+ min) | 62 | $9,805 | $114 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $9,029 | $146 |
| Short return visit (20+ min) | 41 | $3,800 | $78 |
| Influenza vaccine split virus, preservative free | 15 | $979 | $65 |
| Administration of influenza virus vaccine | 16 | $350 | $22 |
2020: 7 services
| Long return visit (40+ min) | 54 | $11,291 | $133 |
| Return visit (30+ min) | 75 | $9,561 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,221 | $141 |
| Short return visit (20+ min) | 25 | $1,534 | $61 |
| Influenza vaccine split virus, preservative free | 25 | $1,503 | $60 |
| Administration of influenza virus vaccine | 25 | $522 | $21 |
| Administration of pneumococcal vaccine | 12 | $248 | $21 |
2019: 8 services
| Long return visit (40+ min) | 69 | $12,050 | $113 |
| Return visit (30+ min) | 82 | $11,017 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $7,548 | $140 |
| Short return visit (20+ min) | 24 | $1,469 | $59 |
| Pneumococcal vaccine, 23-valent | 11 | $1,219 | $111 |
| Influenza vaccine split virus, preservative free | 21 | $1,105 | $53 |
| Administration of influenza virus vaccine | 25 | $513 | $21 |
| Administration of pneumococcal vaccine | 13 | $267 | $21 |
2018: 8 services
| Long return visit (40+ min) | 60 | $11,692 | $121 |
| Return visit (30+ min) | 78 | $9,574 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 63 | $8,273 | $131 |
| Pneumococcal vaccine, 13-valent | 12 | $2,388 | $199 |
| Short return visit (20+ min) | 21 | $1,179 | $56 |
| Influenza vaccine split virus, preservative free | 23 | $1,038 | $43 |
| Administration of influenza virus vaccine | 25 | $669 | $26 |
| Administration of pneumococcal vaccine | 19 | $489 | $26 |
2017: 7 services
| Return visit (30+ min) | 82 | $10,382 | $89 |
| Long return visit (40+ min) | 61 | $9,140 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | $6,625 | $127 |
| Short return visit (20+ min) | 17 | $996 | $59 |
| Influenza vaccine split virus, preservative free | 14 | $641 | $43 |
| Administration of influenza virus vaccine | 18 | $606 | $32 |
| Administration of pneumococcal vaccine | 13 | $395 | $30 |
2016: 8 services
| Return visit (30+ min) | 83 | $11,059 | $83 |
| Long return visit (40+ min) | 43 | $6,453 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,540 | $126 |
| Pneumococcal vaccine, 13-valent | 26 | $4,505 | $173 |
| Short return visit (20+ min) | 31 | $1,549 | $48 |
| Administration of pneumococcal vaccine | 30 | $911 | $30 |
| Influenza vaccine split virus, preservative free | 16 | $652 | $36 |
| Administration of influenza virus vaccine | 18 | $608 | $30 |
2015: 9 services
| Return visit (30+ min) | 68 | $9,099 | $94 |
| Pneumococcal vaccine, 13-valent | 43 | $6,526 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,718 | $131 |
| Long return visit (40+ min) | 13 | $3,425 | $137 |
| Short return visit (20+ min) | 42 | $2,755 | $54 |
| Administration of pneumococcal vaccine | 44 | $1,337 | $30 |
| Administration of influenza virus vaccine | 23 | $729 | $32 |
| Short return visit | 13 | $334 | $26 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $196 | $18 |
2014: 6 services
| Return visit (30+ min) | 59 | $6,962 | $79 |
| Long return visit (40+ min) | 24 | $4,003 | $121 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $1,891 | $126 |
| Short return visit (20+ min) | 27 | $1,688 | $56 |
| Administration of influenza virus vaccine | 15 | $486 | $30 |
| Influenza vaccine split virus, preservative free | 11 | $360 | $33 |
2013: 3 services
| Return visit (30+ min) | 46 | $7,849 | $85 |
| Long return visit (40+ min) | 18 | $3,036 | $117 |
| Short return visit (20+ min) | 28 | $2,570 | $58 |
Drugs they prescribed that Part D paid
$56,604
Pharmacies billed $56,604 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,162 generic and 114 brand-name prescriptions · $56,604 in drug cost · 20 antibiotic prescriptions to 15 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breo Ellipta | 11 | $10,191 | $926 |
| Rosuvastatin | 66 | $1,103 | $17 |
| Atorvastatin | 135 | $1,028 | $8 |
| Synthroid | 14 | $907 | $65 |
| Gabapentin | 33 | $877 | $27 |
See all 29 drugs
| Breo Ellipta | 11 | $10,191 | $926 |
| Rosuvastatin | 66 | $1,103 | $17 |
| Atorvastatin | 135 | $1,028 | $8 |
| Synthroid | 14 | $907 | $65 |
| Gabapentin | 33 | $877 | $27 |
| Fluoxetine | 35 | $826 | $24 |
| Valsartan | 24 | $743 | $31 |
| Losartan | 63 | $652 | $10 |
| Bupropion Xl | 15 | $607 | $40 |
| Levothyroxine | 53 | $557 | $11 |
| Escitalopram | 35 | $501 | $14 |
| Paroxetine | 26 | $459 | $18 |
| Hydrochlorothiazide | 60 | $398 | $7 |
| Lisinopril | 59 | $377 | $6 |
| Amlodipine Besylate | 69 | $326 | $5 |
| Venlafaxine Hcl Er | 14 | $301 | $22 |
| Tamsulosin | 27 | $293 | $11 |
| Hydroxyzine | 15 | $289 | $19 |
| Potassium Chloride | 18 | $255 | $14 |
| Metformin Hcl Er | 17 | $187 | $11 |
| Trazodone | 18 | $172 | $10 |
| Pantoprazole | 18 | $100 | $6 |
| Metoprolol | 13 | $89 | $7 |
| Omeprazole | 12 | $77 | $6 |
| Metformin | 12 | $67 | $6 |
| Ciclopirox | 11 | $66 | $6 |
| Sertraline | 11 | $54 | $5 |
| Atenolol | 12 | $44 | $4 |
| Allopurinol | 11 | $28 | $3 |
Year by year
| 2024 | 1,276 | 146 | None | 9% | $56,604 |
| 2023 | 1,290 | 146 | None | None | $76,442 |
| 2022 | 1,196 | 142 | 1% (11) | 10% | $73,192 |
| 2021 | 1,150 | 121 | 3% (29) | 12% | $68,935 |
| 2020 | 1,113 | 112 | 1% (15) | None | $73,262 |
| 2019 | 1,051 | 104 | None | None | $65,261 |
| 2018 | 1,127 | 119 | 2% (21) | None | $64,247 |
| 2017 | 924 | 128 | 2% (19) | None | $56,849 |
| 2016 | 828 | 123 | 3% (24) | 17% | $46,873 |
| 2015 | 758 | 97 | 3% (24) | None | $47,763 |
| 2014 | 826 | 76 | 3% (26) | None | $66,359 |
| 2013 | 857 | 79 | 3% (29) | 23% | $47,858 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Synthroid | 20 | $1,439 | $72 |
| Valsartan | 23 | $1,126 | $49 |
| Levothyroxine | 67 | $964 | $14 |
| Gabapentin | 35 | $927 | $26 |
| Rosuvastatin | 48 | $856 | $18 |
| Losartan | 71 | $828 | $12 |
| Atorvastatin | 103 | $788 | $8 |
| Amlodipine Besylate | 73 | $673 | $9 |
| Diclofenac | 11 | $618 | $56 |
| Metformin Hcl Er | 21 | $534 | $25 |
| Hydrochlorothiazide | 72 | $476 | $7 |
| Trazodone | 19 | $454 | $24 |
| Escitalopram | 31 | $412 | $13 |
| Tamsulosin | 15 | $387 | $26 |
| Potassium Chloride | 13 | $378 | $29 |
| Fluoxetine | 19 | $354 | $19 |
| Fluticasone Propionate | 17 | $338 | $20 |
| Venlafaxine Hcl Er | 11 | $285 | $26 |
| Lisinopril | 56 | $281 | $5 |
| Paroxetine | 14 | $237 | $17 |
| Allopurinol | 15 | $228 | $15 |
| Pantoprazole | 11 | $227 | $21 |
| Hydralazine | 12 | $226 | $19 |
| Atenolol | 21 | $211 | $10 |
| Furosemide | 16 | $119 | $7 |
| Metformin | 13 | $88 | $7 |
| Sertraline | 12 | $85 | $7 |
| Metoprolol | 12 | $83 | $7 |
2022: 31 drugs
| Eliquis | 12 | $9,770 | $814 |
| Gabapentin | 30 | $1,197 | $40 |
| Synthroid | 12 | $1,177 | $98 |
| Levothyroxine | 72 | $1,176 | $16 |
| Losartan | 77 | $1,022 | $13 |
| Rosuvastatin | 38 | $804 | $21 |
| Atorvastatin | 79 | $802 | $10 |
| Bupropion Xl | 13 | $783 | $60 |
| Valsartan | 17 | $747 | $44 |
| Hydrochlorothiazide | 61 | $563 | $9 |
| Lisinopril | 54 | $503 | $9 |
| Metformin Hcl Er | 14 | $468 | $33 |
| Amlodipine Besylate | 70 | $429 | $6 |
| Fluticasone Propionate | 18 | $427 | $24 |
| Escitalopram | 20 | $385 | $19 |
| Triamcinolone Acetonide | 18 | $382 | $21 |
| Allopurinol | 17 | $282 | $17 |
| Potassium Chloride | 15 | $266 | $18 |
| Famotidine | 12 | $256 | $21 |
| Metformin | 13 | $253 | $19 |
| Paroxetine | 12 | $212 | $18 |
| Simvastatin | 13 | $212 | $16 |
| Trazodone | 22 | $184 | $8 |
| Ketoconazole | 13 | $183 | $14 |
| Lovastatin | 19 | $137 | $7 |
| Paxlovid (Eua) | 13 | $135 | $10 |
| Atenolol | 23 | $120 | $5 |
| Olmesartan Medoxomil | 11 | $99 | $9 |
| Furosemide | 11 | $86 | $8 |
| Metoprolol | 11 | $83 | $8 |
| Sertraline | 11 | $75 | $7 |
2021: 21 drugs
| Levothyroxine | 86 | $1,981 | $23 |
| Rosuvastatin | 41 | $1,532 | $37 |
| Atorvastatin | 75 | $1,526 | $20 |
| Valsartan | 17 | $1,078 | $63 |
| Losartan | 60 | $928 | $15 |
| Amlodipine Besylate | 66 | $701 | $11 |
| Metformin Hcl Er | 23 | $695 | $30 |
| Hydrochlorothiazide | 60 | $601 | $10 |
| Lisinopril | 67 | $577 | $9 |
| Gabapentin | 20 | $462 | $23 |
| Metoprolol | 16 | $435 | $27 |
| Simvastatin | 23 | $407 | $18 |
| Allopurinol | 17 | $385 | $23 |
| Paroxetine | 12 | $251 | $21 |
| Atenolol | 23 | $247 | $11 |
| Escitalopram | 18 | $188 | $10 |
| Lovastatin | 15 | $174 | $12 |
| Acetaminophen-Codeine | 18 | $170 | $9 |
| Trazodone | 19 | $143 | $8 |
| Famotidine | 14 | $136 | $10 |
| Alprazolam | 11 | $53 | $5 |
2020: 25 drugs
| Combivent Respimat | 12 | $4,975 | $415 |
| Lantus | 11 | $3,268 | $297 |
| Levothyroxine | 91 | $2,377 | $26 |
| Estradiol | 13 | $2,125 | $163 |
| Atorvastatin | 77 | $1,262 | $16 |
| Valsartan | 18 | $1,126 | $63 |
| Rosuvastatin | 29 | $1,077 | $37 |
| Potassium Chloride | 11 | $934 | $85 |
| Losartan | 64 | $656 | $10 |
| Amlodipine Besylate | 71 | $581 | $8 |
| Gabapentin | 26 | $524 | $20 |
| Allopurinol | 16 | $429 | $27 |
| Metformin Hcl Er | 16 | $409 | $26 |
| Lisinopril | 51 | $372 | $7 |
| Bupropion Xl | 11 | $366 | $33 |
| Hydrochlorothiazide | 42 | $313 | $7 |
| Atenolol | 21 | $294 | $14 |
| Paroxetine | 12 | $225 | $19 |
| Simvastatin | 22 | $216 | $10 |
| Fluoxetine | 14 | $216 | $15 |
| Metoprolol | 19 | $181 | $10 |
| Sertraline | 11 | $167 | $15 |
| Omeprazole | 13 | $156 | $12 |
| Quetiapine | 11 | $147 | $13 |
| Metformin | 13 | $130 | $10 |
2019: 24 drugs
| Potassium Chloride | 17 | $2,047 | $120 |
| Levothyroxine | 80 | $2,006 | $25 |
| Atorvastatin | 81 | $1,465 | $18 |
| Valsartan | 18 | $1,455 | $81 |
| Gabapentin | 23 | $837 | $36 |
| Mirtazapine | 12 | $672 | $56 |
| Losartan | 32 | $548 | $17 |
| Ranitidine | 37 | $447 | $12 |
| Atenolol | 28 | $417 | $15 |
| Pravastatin | 14 | $374 | $27 |
| Lisinopril | 43 | $368 | $9 |
| Hydrochlorothiazide | 40 | $366 | $9 |
| Spironolactone-Hctz | 11 | $363 | $33 |
| Simvastatin | 34 | $346 | $10 |
| Trazodone | 14 | $322 | $23 |
| Omeprazole | 20 | $301 | $15 |
| Paroxetine | 17 | $294 | $17 |
| Amlodipine Besylate | 50 | $286 | $6 |
| Metformin | 20 | $241 | $12 |
| Allopurinol | 11 | $227 | $21 |
| Fluoxetine | 13 | $216 | $17 |
| Furosemide | 17 | $165 | $10 |
| Buspirone | 11 | $145 | $13 |
| Metoprolol | 14 | $53 | $4 |
2018: 27 drugs
| Levothyroxine | 76 | $1,749 | $23 |
| Potassium Chloride | 16 | $1,577 | $99 |
| Atorvastatin | 76 | $1,406 | $19 |
| Valsartan | 14 | $1,361 | $97 |
| Pravastatin | 23 | $715 | $31 |
| Ranitidine | 15 | $569 | $38 |
| Nitrofurantoin | 11 | $561 | $51 |
| Gabapentin | 26 | $436 | $17 |
| Metformin | 33 | $419 | $13 |
| Valacyclovir | 15 | $398 | $27 |
| Lisinopril | 66 | $376 | $6 |
| Hydrochlorothiazide | 38 | $367 | $10 |
| Allopurinol | 14 | $355 | $25 |
| Simvastatin | 31 | $304 | $10 |
| Metoprolol | 11 | $295 | $27 |
| Atenolol | 26 | $280 | $11 |
| Pantoprazole | 15 | $255 | $17 |
| Amlodipine Besylate | 50 | $247 | $5 |
| Fluoxetine | 17 | $246 | $14 |
| Lovastatin | 11 | $237 | $22 |
| Polyethylene Glycol 3350 | 11 | $226 | $21 |
| Losartan | 27 | $215 | $8 |
| Escitalopram | 11 | $206 | $19 |
| Omeprazole | 14 | $187 | $13 |
| Paroxetine | 13 | $139 | $11 |
| Metoprolol | 20 | $96 | $5 |
| Furosemide | 15 | $62 | $4 |
2017: 17 drugs
| Combivent Respimat | 12 | $4,163 | $347 |
| Levothyroxine | 76 | $2,329 | $31 |
| Ranitidine | 15 | $1,748 | $117 |
| Valsartan | 12 | $1,584 | $132 |
| Atorvastatin | 45 | $986 | $22 |
| Pravastatin | 26 | $529 | $20 |
| Lisinopril | 83 | $497 | $6 |
| Allopurinol | 14 | $441 | $32 |
| Oxybutynin Chloride | 11 | $409 | $37 |
| Hydrochlorothiazide | 36 | $403 | $11 |
| Metformin | 36 | $347 | $10 |
| Alendronate | 15 | $204 | $14 |
| Amlodipine Besylate | 31 | $175 | $6 |
| Atenolol | 26 | $167 | $6 |
| Simvastatin | 16 | $138 | $9 |
| Losartan | 15 | $131 | $9 |
| Metoprolol | 13 | $81 | $6 |
2016: 22 drugs
| Combivent Respimat | 11 | $3,468 | $315 |
| Valsartan | 14 | $3,368 | $241 |
| Qvar | 11 | $2,862 | $260 |
| Levothyroxine | 67 | $1,916 | $29 |
| Ranitidine | 11 | $1,341 | $122 |
| Atorvastatin | 43 | $992 | $23 |
| Lisinopril | 63 | $591 | $9 |
| Pravastatin | 15 | $408 | $27 |
| Hydrocodone-Acetaminophen | 13 | $383 | $29 |
| Hydrochlorothiazide | 29 | $382 | $13 |
| Oxybutynin Chloride | 12 | $324 | $27 |
| Metformin | 30 | $317 | $11 |
| Amlodipine Besylate | 30 | $274 | $9 |
| Dextroamphetamine-Amphetamine | 11 | $273 | $25 |
| Fluoxetine | 12 | $237 | $20 |
| Losartan | 25 | $223 | $9 |
| Fluticasone Propionate | 11 | $211 | $19 |
| Atenolol | 15 | $164 | $11 |
| Simvastatin | 15 | $155 | $10 |
| Metoprolol | 14 | $143 | $10 |
| Progesterone | 13 | $135 | $10 |
| Furosemide | 13 | $23 | $2 |
2015: 20 drugs
| Combivent Respimat | 12 | $3,788 | $316 |
| Levothyroxine | 55 | $1,686 | $31 |
| Losartan | 24 | $619 | $26 |
| Atorvastatin | 30 | $444 | $15 |
| Carvedilol | 17 | $425 | $25 |
| Lisinopril | 50 | $344 | $7 |
| Hydrochlorothiazide | 22 | $326 | $15 |
| Oxybutynin Chloride | 12 | $302 | $25 |
| Metformin | 24 | $247 | $10 |
| Amlodipine Besylate | 28 | $216 | $8 |
| Hydrocodone-Acetaminophen | 12 | $215 | $18 |
| Omeprazole | 18 | $187 | $10 |
| Fluticasone Propionate | 11 | $172 | $16 |
| Atenolol | 12 | $147 | $12 |
| Lovastatin | 12 | $135 | $11 |
| Simvastatin | 12 | $110 | $9 |
| Venlafaxine Hcl Er | 14 | $108 | $8 |
| Lorazepam | 13 | $90 | $7 |
| Diazepam | 11 | $68 | $6 |
| Furosemide | 16 | $35 | $2 |
2014: 20 drugs
| Duloxetine | 14 | $3,123 | $223 |
| Qvar | 11 | $1,982 | $180 |
| Levothyroxine | 47 | $1,120 | $24 |
| Atorvastatin | 38 | $1,054 | $28 |
| Proair Hfa | 16 | $772 | $48 |
| Losartan | 26 | $491 | $19 |
| Gabapentin | 11 | $418 | $38 |
| Amlodipine Besylate | 27 | $347 | $13 |
| Carvedilol | 16 | $336 | $21 |
| Lisinopril | 42 | $327 | $8 |
| Metformin | 22 | $313 | $14 |
| Venlafaxine Hcl Er | 22 | $252 | $11 |
| Hydrochlorothiazide | 22 | $225 | $10 |
| Omeprazole | 16 | $221 | $14 |
| Simvastatin | 12 | $221 | $18 |
| Atenolol | 23 | $203 | $9 |
| Zolpidem | 18 | $190 | $11 |
| Hydrocodone-Acetaminophen | 13 | $187 | $14 |
| Furosemide | 32 | $139 | $4 |
| Lorazepam | 13 | $128 | $10 |
2013: 26 drugs
| Flovent Hfa | 13 | $2,621 | $202 |
| Evista | 12 | $2,168 | $181 |
| Humulin 70-30 | 12 | $1,909 | $159 |
| Estradiol | 11 | $1,437 | $131 |
| Valacyclovir | 13 | $1,256 | $97 |
| Losartan | 20 | $722 | $36 |
| Levothyroxine | 44 | $633 | $14 |
| Diltiazem 24hr Cd | 19 | $610 | $32 |
| Synthroid | 13 | $510 | $39 |
| Fluoxetine | 12 | $494 | $41 |
| Atorvastatin | 21 | $476 | $23 |
| Metformin | 32 | $424 | $13 |
| Amlodipine Besylate | 27 | $415 | $15 |
| Omeprazole | 26 | $393 | $15 |
| Carvedilol | 16 | $323 | $20 |
| Lisinopril | 38 | $316 | $8 |
| Lovastatin | 17 | $303 | $18 |
| Alendronate | 12 | $283 | $24 |
| Simvastatin | 14 | $228 | $16 |
| Hydrochlorothiazide | 23 | $189 | $8 |
| Atenolol | 24 | $186 | $8 |
| Furosemide | 28 | $156 | $6 |
| Acetaminophen-Codeine | 13 | $138 | $11 |
| Potassium Chloride | 12 | $134 | $11 |
| Hydrocodone-Acetaminophen | 12 | $97 | $8 |
| Lorazepam | 12 | $84 | $7 |
Professional record
- NPI
- 1407969132
- Licence
- CA G79646California G79646: Current · expires 2028-07-31
- Trained
- University of California, Davis School of Medicine, 1992
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-08-16
- NPI last updated
- 2020-05-20
- NPI record certified
- 2020-05-20
This is when the NPI record was last certified, not a medical board exam.